Can a lactating mother safely receive chlorpheniramine injection (Avil) while breastfeeding her 11‑month‑old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlorpheniramine Injection (Avil) is Generally Safe During Breastfeeding for an 11-Month-Old Infant

Chlorpheniramine can be safely administered to a lactating mother with an 11-month-old infant, as antihistamines are excreted in minimal amounts in breast milk and are unlikely to cause adverse effects in breastfeeding infants. 1

Evidence Supporting Safety

Antihistamine Safety Profile in Lactation

First-generation antihistamines like chlorpheniramine have been extensively studied and are considered compatible with breastfeeding. Research confirms that all antihistamines are considered safe to use during breastfeeding, as minimal amounts are excreted in breast milk and would not cause any adverse effects on a breastfeeding infant 1. This is particularly reassuring for an 11-month-old infant who is likely consuming solid foods in addition to breast milk, further diluting any potential drug exposure.

Pharmacokinetic Advantages

The safety profile is supported by favorable pharmacokinetic properties:

  • Minimal transfer into breast milk due to the drug's characteristics
  • The infant's age (11 months) provides additional safety margin compared to newborns, as older infants have more mature hepatic and renal clearance mechanisms
  • Any drug that does transfer would be further diluted by the infant's larger volume of distribution and complementary diet

Clinical Considerations

Timing and Monitoring

While no specific waiting period is required, you can optimize safety by:

  • Administering the injection immediately after a breastfeeding session
  • Observing the infant for unusual drowsiness or irritability (though this is unlikely at therapeutic doses)
  • Being aware that sedation is the primary theoretical concern with first-generation antihistamines

Important Caveats

Watch for sedation: First-generation antihistamines like chlorpheniramine can cause maternal sedation, which may indirectly affect infant care. The mother should be advised about this potential effect on her ability to safely care for her infant 1.

Single dose vs. repeated dosing: The evidence strongly supports safety for single-dose or short-term use. If prolonged therapy is needed, consider whether a non-sedating second-generation antihistamine might be more appropriate, though published studies on these are also reassuring 1.

Broader Context

The general principle for medication use during lactation applies here: most medications are compatible with breastfeeding, and the benefits of continued breastfeeding typically outweigh theoretical risks from minimal drug exposure 2, 3. The decision to interrupt breastfeeding should not be taken lightly given the significant health benefits of lactation for both mother and child 4.

References

Research

Safety of antihistamines during pregnancy and lactation.

Canadian family physician Medecin de famille canadien, 2010

Research

Medications in pregnancy and lactation.

Emergency medicine clinics of North America, 2003

Research

Drugs in lactation.

The journal of obstetrics and gynaecology research, 2019

Related Questions

Can chlorpheniramine (Avil) be taken together with dexamethasone (Dexona)?
Can a pregnant woman safely use Allergex (chlorpheniramine), and what dosage and alternatives are recommended?
Can Avil (chlorpheniramine maleate) be administered intravenously as 2 cc undiluted solution?
Can a lactating mother safely take Gravol (dimenhydrinate) and Gas X (simethicone)?
Can chlorpheniramine be used safely for less than one year, and what are the appropriate dosing and safety considerations?
Should an elderly patient be given Ativan (lorazepam) 0.25 mg every 8 hours as needed for behavioral disturbance and rage?
For a patient with a subtle lucency through the dorsal aspect of the fourth middle phalanx epiphysis seen only on lateral radiograph, indicating a nondisplaced fracture, should this be referred to plastic surgery or can it be managed in primary care with splinting?
What are the groups of gadolinium-based MRI contrast agents and which agents belong to each group?
What is the recommended treatment for atopic dermatitis behind the ears with a fungal component?
What are the Canadian Psychiatric Association's guidelines for monitoring antipsychotic therapy, including baseline assessments, laboratory and electrocardiogram monitoring, extrapyramidal symptom evaluation, and clozapine-specific white‑blood‑cell monitoring?
In a Crohn's disease patient who has been in remission for 9 years on vedolizumab (Entyvio), how long can remission be maintained and how long should the therapy be continued?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.